Cargando…
Point mutations in the tumor suppressor Smad4/DPC4 enhance its phosphorylation by GSK3 and reversibly inactivate TGF-β signaling
The tumor suppressor Smad4/DPC4 is an essential transcription factor in the TGF-β pathway and is frequently mutated or deleted in prostate, colorectal, and pancreatic carcinomas. We recently discovered that Smad4 activity and stability are regulated by the FGF/EGF and Wnt signaling pathways through...
Autores principales: | Demagny, Hadrien, De Robertis, Edward M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845174/ https://www.ncbi.nlm.nih.gov/pubmed/27308538 http://dx.doi.org/10.1080/23723556.2015.1025181 |
Ejemplares similares
-
Smad4/DPC4: A barrier against tumor progression driven by RTK/Ras/Erk and Wnt/GSK3 signaling
por: Demagny, Hadrien, et al.
Publicado: (2015) -
Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998) -
Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?
por: Ungefroren, Hendrik, et al.
Publicado: (2023) -
Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3ε
por: Liffers, Sven-T, et al.
Publicado: (2011) -
DPC4 Expression in the Small Intestinal Adenocarcinomas
por: Lee, Sun Jae, et al.
Publicado: (2012)